Loading...

Barry Massie, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentMedicine
AddressVAMC 203
San Francisco CA 94121
Phone415-750-2112
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency Cardiology

    Collapse Research 
    Collapse Research Activities and Funding
    General Clinical Research Center
    NIH/NCRR M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Biegus J, Hillege HL, Postmus D, Valente MA, Bloomfield DM, Cleland JG, Cotter G, Davison BA, Dittrich HC, Fiuzat M, Givertz MM, Massie BM, Metra M, Teerlink JR, Voors AA, O'Connor CM, Ponikowski P. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. Eur J Heart Fail. 2016 Jul; 18(7):830-9. PMID: 27170455.
      View in: PubMed
    2. Davison BA, Metra M, Senger S, Edwards C, Milo O, Bloomfield DM, Cleland JG, Dittrich HC, Givertz MM, O'Connor CM, Massie BM, Ponikowski P, Teerlink JR, Voors AA, Cotter G. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. Eur J Heart Fail. 2016 Aug; 18(8):1041-50. PMID: 27114058.
      View in: PubMed
    3. McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. N Engl J Med. 2016 Apr 21; 374(16):1521-32. PMID: 27043774.
      View in: PubMed
    4. Krum H, McMurray JJ, Abraham WT, Dickstein K, Køber L, Desai AS, Solomon SD, Chiang Y, Gimpelewicz C, Reimund B, Ali MA, Tarnesby G, Massie BM. The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics. Eur J Heart Fail. 2015 Oct; 17(10):1075-83. PMID: 26511146.
      View in: PubMed
    5. Kao DP, Lewsey JD, Anand IS, Massie BM, Zile MR, Carson PE, McKelvie RS, Komajda M, McMurray JJ, Lindenfeld J. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail. 2015 Sep; 17(9):925-35. PMID: 26250359; PMCID: PMC4654630.
    6. Heidenreich PA, Sahay A, Mittman BS, Oliva N, Gholami P, Rumsfeld JS, Massie BM. Facilitation of a Multihospital Community of Practice to Increase Enrollment in the Hospital to Home National Quality Improvement Initiative. Jt Comm J Qual Patient Saf. 2015 Aug; 41(8):361-9. PMID: 26215525.
      View in: PubMed
    7. Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 2015 Jun; 3(6):429-441. PMID: 25982110.
      View in: PubMed
    8. Davison BA, Metra M, Cotter G, Massie BM, Cleland JG, Dittrich HC, Edwards C, Filippatos G, Givertz MM, Greenberg B, Ponikowski P, Voors AA, O'Connor CM, Teerlink JR. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies. JACC Heart Fail. 2015 May; 3(5):395-403. PMID: 25951761.
      View in: PubMed
    9. Cowie MR, Anker SD, Cleland JGF, Felker GM, Filippatos G, Jaarsma T, Jourdain P, Knight E, Massie B, Ponikowski P, López-Sendón J. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail. 2014 Dec; 1(2):110-145. PMID: 28834628.
      View in: PubMed
    10. Metra M, Mentz RJ, Chiswell K, Bloomfield DM, Cleland JG, Cotter G, Davison BA, Dittrich HC, Fiuzat M, Givertz MM, Lazzarini V, Mansoor GA, Massie BM, Ponikowski P, Teerlink JR, Voors AA, O'Connor CM. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. Eur J Heart Fail. 2015 Jan; 17(1):109-18. PMID: 25431336.
      View in: PubMed
    11. Tang WH, Dupont M, Hernandez AF, Voors AA, Hsu AP, Felker GM, Butler J, Metra M, Anker SD, Troughton RW, Gottlieb SS, McMurray JJ, Armstrong PW, Massie BM, Califf RM, O'Connor CM, Starling RC. Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. JACC Heart Fail. 2015 Jan; 3(1):40-9. PMID: 25453534.
      View in: PubMed
    12. Adabag S, Rector TS, Anand IS, McMurray JJ, Zile M, Komajda M, McKelvie RS, Massie B, Carson PE. A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2014 Nov; 16(11):1175-82. PMID: 25302657.
      View in: PubMed
    13. Oluleye OW, Rector TS, Win S, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Massie B, Carson PE, Anand IS. History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):960-6. PMID: 25225241.
      View in: PubMed
    14. Böhm M, Perez AC, Jhund PS, Reil JC, Komajda M, Zile MR, McKelvie RS, Anand IS, Massie BM, Carson PE, McMurray JJ. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). Eur J Heart Fail. 2014 Jul; 16(7):778-87. PMID: 24864045.
      View in: PubMed
    15. Mentz RJ, Cotter G, Cleland JG, Stevens SR, Chiswell K, Davison BA, Teerlink JR, Metra M, Voors AA, Grinfeld L, Ruda M, Mareev V, Lotan C, Bloomfield DM, Fiuzat M, Givertz MM, Ponikowski P, Massie BM, O'Connor CM. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial. Eur J Heart Fail. 2014 Jun; 16(6):614-24. PMID: 24771609.
      View in: PubMed
    16. Kalogeropoulos AP, Tang WH, Hsu A, Felker GM, Hernandez AF, Troughton RW, Voors AA, Anker SD, Metra M, McMurray JJ, Massie BM, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Butler J. High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. J Card Fail. 2014 May; 20(5):319-26. PMID: 24530944.
      View in: PubMed
    17. Shalaby AA, Brumberg GE, Pointer L, Bekelman DB, Rumsfeld JS, Yang Y, Pellegrini CN, Heidenreich PA, Keung E, Massie BM, Varosy PD. Depression and outcome among veterans with implantable cardioverter defibrillators with or without cardiac resynchronization therapy capability. Pacing Clin Electrophysiol. 2014 Aug; 37(8):994-1001. PMID: 24520992.
      View in: PubMed
    18. Toma M, Ezekowitz JA, Bakal JA, O'Connor CM, Hernandez AF, Sardar MR, Zolty R, Massie BM, Swedberg K, Armstrong PW, Starling RC. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial. Eur J Heart Fail. 2014 Mar; 16(3):334-41. PMID: 24464687.
      View in: PubMed
    19. Meyer S, van der Meer P, Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL, Voors AA. Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail. 2013 Dec; 15(12):1374-81. PMID: 24259042.
      View in: PubMed
    20. Givertz MM, Postmus D, Hillege HL, Mansoor GA, Massie BM, Davison BA, Ponikowski P, Metra M, Teerlink JR, Cleland JG, Dittrich HC, O'Connor CM, Cotter G, Voors AA. Renal function trajectories and clinical outcomes in acute heart failure. Circ Heart Fail. 2014 Jan; 7(1):59-67. PMID: 24281137.
      View in: PubMed
    21. Cleland JG, Chiswell K, Teerlink JR, Stevens S, Fiuzat M, Givertz MM, Davison BA, Mansoor GA, Ponikowski P, Voors AA, Cotter G, Metra M, Massie BM, O'Connor CM. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. Circ Heart Fail. 2014 Jan; 7(1):76-87. PMID: 24281134.
      View in: PubMed
    22. Heidenreich PA, Lin S, Knowles JW, Perez M, Maddox TM, Ho MP, Rumsfeld JS, Sahay A, Massie BM, Tsai TT, Witteles RM. Variation in use of left ventriculography in the Veterans Affairs Health Care System. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):687-93. PMID: 24192569.
      View in: PubMed
    23. Gheorghiade M, Vaduganathan M, Fonarow GC, Greene SJ, Greenberg BH, Liu PP, Massie BM, Mehra MR, Metra M, Zannad F, Cleland JG, van Veldhuisen DJ, Shah AN, Butler J. Anticoagulation in heart failure: current status and future direction. Heart Fail Rev. 2013 Nov; 18(6):797-813. PMID: 22987320.
      View in: PubMed
    24. Reed SD, Kaul P, Li Y, Eapen ZJ, Davidson-Ray L, Schulman KA, Massie BM, Armstrong PW, Starling RC, O'Connor CM, Hernandez AF, Califf RM. Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF. J Card Fail. 2013 Sep; 19(9):611-20. PMID: 24054337.
      View in: PubMed
    25. Homma S, Thompson JL, Sanford AR, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Massie BM, Labovitz AJ, Di Tullio MR, Gabriel AP, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD. Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial. Circ Heart Fail. 2013 Sep 01; 6(5):988-97. PMID: 23881846; PMCID: PMC4242511.
    26. Lesogor A, Cohn JN, Latini R, Tognoni G, Krum H, Massie B, Zalewski A, Kandra A, Hua TA, Gimpelewicz C. Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study. Eur J Heart Fail. 2013 Nov; 15(11):1236-44. PMID: 23787721.
      View in: PubMed
    27. Eapen ZJ, Reed SD, Li Y, Kociol RD, Armstrong PW, Starling RC, McMurray JJ, Massie BM, Swedberg K, Ezekowitz JA, Fonarow GC, Teerlink JR, Metra M, Whellan DJ, O'Connor CM, Califf RM, Hernandez AF. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF. Circ Heart Fail. 2013 Jul; 6(4):727-32. PMID: 23770519.
      View in: PubMed
    28. Milfred-LaForest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy. 2013 May; 33(5):529-48. PMID: 23649813.
      View in: PubMed
    29. Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013 May; 19(5):354-69. PMID: 23663818.
      View in: PubMed
    30. Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail. 2013 Apr; 1(2):103-11. PMID: 24621834.
      View in: PubMed
    31. van der Meer P, Postmus D, Ponikowski P, Cleland JG, O'Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol. 2013 May 14; 61(19):1973-81. PMID: 23500313.
      View in: PubMed
    32. Mentz RJ, Hernandez AF, Stebbins A, Ezekowitz JA, Felker GM, Heizer GM, Atar D, Teerlink JR, Califf RM, Massie BM, Hasselblad V, Starling RC, O'Connor CM, Ponikowski P. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. Eur J Heart Fail. 2013 Apr; 15(4):456-64. PMID: 23159547; PMCID: PMC3605752.
    33. Lam CS, Carson PE, Anand IS, Rector TS, Kuskowski M, Komajda M, McKelvie RS, McMurray JJ, Zile MR, Massie BM, Kitzman DW. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2012 Sep 01; 5(5):571-8. PMID: 22887722; PMCID: PMC4768740.
    34. Sung RK, Massie BM, Varosy PD, Moore H, Rumsfeld J, Lee BK, Keung E. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm. 2012 Dec; 9(12):1954-61. PMID: 22871583.
      View in: PubMed
    35. Felker GM, Hasselblad V, Tang WH, Hernandez AF, Armstrong PW, Fonarow GC, Voors AA, Metra M, McMurray JJ, Butler J, Heizer GM, Dickstein K, Massie BM, Atar D, Troughton RW, Anker SD, Califf RM, Starling RC, O'Connor CM. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail. 2012 Nov; 14(11):1257-64. PMID: 22764184.
      View in: PubMed
    36. Costanzo MR, Heywood JT, Massie BM, Iwashita J, Henderson L, Mamatsashvili M, Sisakian H, Hayrapetyan H, Sager P, van Veldhuisen DJ, Albrecht D. A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease. Eur J Heart Fail. 2012 Aug; 14(8):922-30. PMID: 22613585.
      View in: PubMed
    37. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012 May 17; 366(20):1859-69. PMID: 22551105; PMCID: PMC3723382.
    38. O'Connor CM, Mentz RJ, Cotter G, Metra M, Cleland JG, Davison BA, Givertz MM, Mansoor GA, Ponikowski P, Teerlink JR, Voors AA, Fiuzat M, Wojdyla D, Chiswell K, Massie BM. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. Eur J Heart Fail. 2012 Jun; 14(6):605-12. PMID: 22535795.
      View in: PubMed
    39. McMurray JJ, Abraham WT, Dickstein K, Køber L, Massie BM, Krum H. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. Eur J Heart Fail. 2012 Apr; 14(4):341-3. PMID: 22431404; PMCID: PMC3307357.
    40. Teerlink JR, Iragui VJ, Mohr JP, Carson PE, Hauptman PJ, Lovett DH, Miller AB, Piña IL, Thomson S, Varosy PD, Zile MR, Cleland JG, Givertz MM, Metra M, Ponikowski P, Voors AA, Davison BA, Cotter G, Wolko D, Delucca P, Salerno CM, Mansoor GA, Dittrich H, O'Connor CM, Massie BM. The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. Drug Saf. 2012 Mar 01; 35(3):233-44. PMID: 22339573.
      View in: PubMed
    41. Greenberg BH, Anand IS, Burnett JC, Chin J, Dracup KA, Feldman AM, Force T, Francis GS, Houser SR, Hunt SA, Konstam MA, Lindenfeld J, Mann DL, Mehra MR, Paul SC, Piano MR, Ross HJ, Sabbah HN, Starling RC, Udelson JE, Yancy CW, Zile MR, Massie BM. The Heart Failure Society of America in 2020: a vision for the future. J Card Fail. 2012 Feb; 18(2):90-3. PMID: 22300775.
      View in: PubMed
    42. Rector TS, Carson PE, Anand IS, McMurray JJ, Zile MR, McKelvie RS, Komajda M, Kuskowski M, Massie BM. Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial. Circ Heart Fail. 2012 Mar 01; 5(2):217-25. PMID: 22267751.
      View in: PubMed
    43. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011 Dec 06; 124(23):2491-501. PMID: 22064591.
      View in: PubMed
    44. Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Circulation. 2011 Oct 25; 124(17):1811-8. PMID: 21969009; PMCID: PMC3217334.
    45. O'Connor CM, Fiuzat M, Lombardi C, Fujita K, Jia G, Davison BA, Cleland J, Bloomfield D, Dittrich HC, Delucca P, Givertz MM, Mansoor G, Ponikowski P, Teerlink JR, Voors AA, Massie BM, Cotter G, Metra M. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. Circ Heart Fail. 2011 Nov; 4(6):724-32. PMID: 21900185.
      View in: PubMed
    46. Massie BM. Globalization of clinical trials how should we interpret differences in outcomes? J Am Coll Cardiol. 2011 Aug 23; 58(9):923-4. PMID: 21851880.
      View in: PubMed
    47. Krum H, Elsik M, Schneider HG, Ptaszynska A, Black M, Carson PE, Komajda M, Massie BM, McKelvie RS, McMurray JJ, Zile MR, Anand IS. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Circ Heart Fail. 2011 Sep; 4(5):561-8. PMID: 21750125.
      View in: PubMed
    48. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Wilson WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011 Jul 07; 365(1):32-43. PMID: 21732835.
      View in: PubMed
    49. Anand IS, Rector TS, Cleland JG, Kuskowski M, McKelvie RS, Persson H, McMurray JJ, Zile MR, Komajda M, Massie BM, Carson PE. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circ Heart Fail. 2011 Sep; 4(5):569-77. PMID: 21715583.
      View in: PubMed
    50. Steinman MA, Harlow JB, Massie BM, Kaboli PJ, Fung KZ, Heidenreich PA. Age and receipt of guideline-recommended medications for heart failure: a nationwide study of veterans. J Gen Intern Med. 2011 Oct; 26(10):1152-9. PMID: 21604076; PMCID: PMC3181303.
    51. Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, Cotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JG, O'Connor CM, Givertz MM. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol. 2011 May 10; 57(19):1899-907. PMID: 21545947.
      View in: PubMed
    52. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie BM, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation. J Card Fail. 2011 May; 17(5):349-58. PMID: 21549290.
      View in: PubMed
    53. Massie BM. Novel targets for the treatment of heart failure: perspectives from a heart failure clinician and trialist. J Mol Cell Cardiol. 2011 Oct; 51(4):438-40. PMID: 21549124.
      View in: PubMed
    54. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie BM, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. Circ Heart Fail. 2011 May; 4(3):378-87. PMID: 21464151.
      View in: PubMed
    55. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie BM, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. J Am Coll Cardiol. 2011 May 17; 57(20):2115-24. PMID: 21470814.
      View in: PubMed
    56. Metra M, O'Connor CM, Davison BA, Cleland JG, Ponikowski P, Teerlink JR, Voors AA, Givertz MM, Mansoor GA, Bloomfield DM, Jia G, DeLucca P, Massie B, Dittrich H, Cotter G. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J. 2011 Jun; 32(12):1519-34. PMID: 21388992.
      View in: PubMed
    57. Ghali JK, Massie BM, Mann DL, Rich MW. Guidelines are merely guidelines. J Card Fail. 2011 Mar; 17(3):208-9. PMID: 21362528.
      View in: PubMed
    58. Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2011 May; 4(3):324-31. PMID: 21350053; PMCID: PMC3100162.
    59. Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ, Desai A, Gimpelewicz C, Kandra A, Reimund B, Rattunde H, Armbrecht J. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study. Eur J Heart Fail. 2011 Jan; 13(1):107-14. PMID: 21169387.
      View in: PubMed
    60. Ghali JK, Massie BM, Mann DL, Rich MW. Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Card Fail. 2011 Jan; 17(1):90.e1-4. PMID: 21229805.
      View in: PubMed
    61. Ghali JK, Massie BM, Mann DL, Rich MW. Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Am Coll Cardiol. 2010 Dec 14; 56(25):2077-80. PMID: 21144966.
      View in: PubMed
    62. Ghali JK, Massie BM, Mann DL, Rich MW. Guidelines, performance measures, and the practice of medicine: mind the gap. J Card Fail. 2010 Dec; 16(12):915-8. PMID: 21111978.
      View in: PubMed
    63. Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail. 2011 Jan; 4(1):27-35. PMID: 21068341.
      View in: PubMed
    64. Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010 Oct 07; 363(15):1419-28. PMID: 20925544.
      View in: PubMed
    65. Ponikowski P, Mitrovic V, O'Connor CM, Dittrich H, Cotter G, Massie BM, Givertz MM, Chen E, Murray M, Weatherley BD, Fujita KP, Metra M. Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function. Eur J Heart Fail. 2010 Nov; 12(11):1238-46. PMID: 20823097.
      View in: PubMed
    66. Peacock WF, Braunwald E, Abraham W, Albert N, Burnett J, Christenson R, Collins S, Diercks D, Fonarow G, Hollander J, Kellerman A, Gheorghiade M, Kirk D, Levy P, Maisel A, Massie BM, O'Connor C, Pang P, Shah M, Sopko G, Stevenson L, Storrow A, Teerlink J. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J Am Coll Cardiol. 2010 Jul 27; 56(5):343-51. PMID: 20650354.
      View in: PubMed
    67. Heidenreich PA, Sahay A, Kapoor JR, Pham MX, Massie B. Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006. J Am Coll Cardiol. 2010 Jul 27; 56(5):362-8. PMID: 20650356.
      View in: PubMed
    68. Massie BM. Is the effect of angiotensin receptor blockade in patients with heart failure modified by treatment with aspirin? The answer is not so clear! Eur J Heart Fail. 2010 Jul; 12(7):639-41. PMID: 20576831.
      View in: PubMed
    69. Gottlieb SS, Givertz MM, Metra M, Gergich K, Bird S, Jones-Burton C, Massie B, Cotter G, Ponikowski P, Weatherley B, O'Connor C, Dittrich H. The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study. J Card Fail. 2010 Sep; 16(9):714-9. PMID: 20797594.
      View in: PubMed
    70. McCullough PA, Haapio M, Mankad S, Zamperetti N, Massie B, Bellomo R, Berl T, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bobek I, Cruz DN, Daliento L, Davenport A, Hillege H, House AA, Katz N, Maisel A, Mebazaa A, Palazzuoli A, Ponikowski P, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zanco P, Ronco C, Berl T. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010 Jun; 25(6):1777-84. PMID: 20375030.
      View in: PubMed
    71. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation. 2010 Mar 30; 121(12):1393-405. PMID: 20231531.
      View in: PubMed
    72. Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie BM, O'Connor CM, Ponikowski P, Teerlink JR, Voors AA, Cotter G. Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail. 2010 May; 12(5):499-507. PMID: 20228387.
      View in: PubMed
    73. Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010 Mar; 3(2):314-25. PMID: 20233993.
      View in: PubMed
    74. Massie BM. The Journal of Cardiac Failure: passing the baton. J Card Fail. 2010 Jan; 16(1):1. PMID: 20123311.
      View in: PubMed
    75. Weatherley BD, Cotter G, Dittrich HC, DeLucca P, Mansoor GA, Bloomfield DM, Ponikowski P, O'Connor CM, Metra M, Massie BM. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function. J Card Fail. 2010 Jan; 16(1):25-35. PMID: 20123315.
      View in: PubMed
    76. Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). J Am Coll Cardiol. 2009 Nov 24; 54(22):2023-31. PMID: 19926008.
      View in: PubMed
    77. McKelvie RS, Komajda M, McMurray J, Zile M, Ptaszynska A, Donovan M, Carson P, Massie BM. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial. J Card Fail. 2010 Feb; 16(2):128-34. PMID: 20142024.
      View in: PubMed
    78. Cotter G, Metra M, Weatherley BD, Dittrich HC, Massie BM, Ponikowski P, Bloomfield DM, O'Connor CM. Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes. Cardiology. 2010; 115(1):29-36. PMID: 19844102.
      View in: PubMed
    79. Massie BM. Prevention of heart failure with chlorthalidone in ALLHAT: placing the results into perspective. J Clin Hypertens (Greenwich). 2009 Sep; 11(9):462-5. PMID: 19751457.
      View in: PubMed
    80. Patterson ME, Grant WC, Glickman SW, Massie BM, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Teo KK, Schulman KA, Reed SD. Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation. J Card Fail. 2009 Dec; 15(10):819-27. PMID: 19944357.
      View in: PubMed
    81. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009 Jun; 157(6):957-70. PMID: 19464405.
      View in: PubMed
    82. Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation. 2009 Mar 31; 119(12):1616-24. PMID: 19289640.
      View in: PubMed
    83. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009 Feb 03; 119(4):606-18. PMID: 19188521; PMCID: PMC2635942.
    84. Metra M, Dei Cas L, Massie BM. Treatment of heart failure in the elderly: never say it's too late. Eur Heart J. 2009 Feb; 30(4):391-3. PMID: 19181708.
      View in: PubMed
    85. Hernandez AF, O'Connor CM, Starling RC, Reist CJ, Armstrong PW, Dickstein K, Lorenz TJ, Gibler WB, Hasselblad V, Komajda M, Massie B, McMurray JJ, Nieminen M, Rouleau JL, Swedberg K, Califf RM. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). Am Heart J. 2009 Feb; 157(2):271-7. PMID: 19185633.
      View in: PubMed
    86. Ezekowitz JA, Hernandez AF, Starling RC, Yancy CW, Massie B, Hill JA, Krum H, Diaz R, Ponikowski P, Metra M, Howlett JG, Gennevois D, O'Connor CM, Califf RM, Fonarow GC. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). Am Heart J. 2009 Feb; 157(2):219-28. PMID: 19185628.
      View in: PubMed
    87. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008 Dec 04; 359(23):2456-67. PMID: 19001508.
      View in: PubMed
    88. Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation. 2008 Nov 25; 118(22):2259-67. PMID: 19001024; PMCID: PMC2775475.
    89. Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail. 2008 Oct; 14(8):631-40. PMID: 18926433.
      View in: PubMed
    90. Klein L, Massie BM, Leimberger JD, O'Connor CM, Piña IL, Adams KF, Califf RM, Gheorghiade M. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008 May; 1(1):25-33. PMID: 19808267.
      View in: PubMed
    91. Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Circ Heart Fail. 2008 May; 1(1):9-16. PMID: 19808265.
      View in: PubMed
    92. Pang PS, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J. 2008 Mar; 29(6):816-24. PMID: 18310669.
      View in: PubMed
    93. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie BM, Dei Cas L. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail. 2008 Feb; 10(2):188-95. PMID: 18279773.
      View in: PubMed
    94. McMurray JJ, Carson PE, Komajda M, McKelvie R, Zile MR, Ptaszynska A, Staiger C, Donovan JM, Massie BM. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail. 2008 Feb; 10(2):149-56. PMID: 18279770.
      View in: PubMed
    95. Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, Massie BM, Wasserman SM, Trotman ML, Sun Y, Knusel B, Armstrong P. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation. 2008 Jan 29; 117(4):526-35. PMID: 18195176.
      View in: PubMed
    96. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol. 2007 Oct 16; 50(16):1551-60. PMID: 17936154.
      View in: PubMed
    97. Chatterjee K, Massie B. Systolic and diastolic heart failure: differences and similarities. J Card Fail. 2007 Sep; 13(7):569-76. PMID: 17826648.
      View in: PubMed
    98. Massie BM. Review: Available evidence does not support the use of beta blockers as first line treatment for hypertension. Evid Based Med. 2007 Aug; 12(4):112. PMID: 17885160.
      View in: PubMed
    99. Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007 Aug 14; 50(7):600-6. PMID: 17692744.
      View in: PubMed
    100. Fowler MB, Lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B, Massie BM, Abraham WT, Franciosa JA. Beta-blocker dosing in community-based treatment of heart failure. Am Heart J. 2007 Jun; 153(6):1029-36. PMID: 17540206.
      View in: PubMed
    101. Heidenreich PA, Gholami P, Sahay A, Massie B, Goldstein MK. Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of beta-blockers: a randomized trial. Circulation. 2007 Jun 05; 115(22):2829-34. PMID: 17515459.
      View in: PubMed
    102. Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R. The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design. Am Heart J. 2007 Apr; 153(4):478-84. PMID: 17383282.
      View in: PubMed
    103. Massie BM, Nelson JJ, Lukas MA, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, Lottes SR, Franciosa JA. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice. Am J Cardiol. 2007 May 01; 99(9):1263-8. PMID: 17478155.
      View in: PubMed
    104. Einhorn PT, Davis BR, Massie BM, Cushman WC, Piller LB, Simpson LM, Levy D, Nwachuku CE, Black HR. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis. Am Heart J. 2007 Jan; 153(1):42-53. PMID: 17174636.
      View in: PubMed
    105. Marcus GM, Cohen J, Varosy PD, Vessey J, Rose E, Massie BM, Chatterjee K, Waters D. The utility of gestures in patients with chest discomfort. Am J Med. 2007 Jan; 120(1):83-9. PMID: 17208083.
      View in: PubMed
    106. Weber MA, Bakris GL, Dahlöf B, Pitt B, Velazquez E, Gupte J, Lefkowitz M, Hester A, Shi V, Weir M, Kjeldsen S, Massie B, Nesbitt S, Ofili E, Jamerson K. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press. 2007; 16(1):13-9. PMID: 17453747.
      View in: PubMed
    107. Abraham WT, Massie BM, Lukas MA, Lottes SR, Nelson JJ, Fowler MB, Greenberg B, Gilbert EM, Franciosa JA. Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry. Congest Heart Fail. 2007 Jan-Feb; 13(1):16-21. PMID: 17268206.
      View in: PubMed
    108. Franciosa JA, Nelson JJ, Lukas MA, Lottes SR, Massie BM, Fowler MB, Greenberg B, Gilbert EM, Abraham WT. Heart failure in community practice: relationship to age and sex in a beta-blocker registry. Congest Heart Fail. 2006 Nov-Dec; 12(6):317-23. PMID: 17170585.
      View in: PubMed
    109. Greenberg B, Lottes SR, Nelson JJ, Lukas MA, Fowler MB, Massie BM, Abraham WT, Gilbert EM, Franciosa JA. Predictors of clinical outcomes in patients given carvedilol for heart failure. Am J Cardiol. 2006 Dec 01; 98(11):1480-4. PMID: 17126654.
      View in: PubMed
    110. Richard C, Duivenvoorden W, Bourbeau D, Massie B, Roa W, Yau J, Th'ng J. Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy. Cancer Gene Ther. 2007 Jan; 14(1):57-65. PMID: 16874362.
      View in: PubMed
    111. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006 Jun 13; 113(23):2713-23. PMID: 16754803.
      View in: PubMed
    112. Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006 Jun 06; 47(11):2245-52. PMID: 16750691.
      View in: PubMed
    113. Quiñones MA, Zile MR, Massie BM, Kass DA. Chronic heart failure: a report from the Dartmouth Diastole Discourses. Congest Heart Fail. 2006 May-Jun; 12(3):162-5. PMID: 16760702.
      View in: PubMed
    114. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J. 2006 Aug; 27(16):1908-20. PMID: 16682381.
      View in: PubMed
    115. Massie BM, Force T. The year in heart failure 2005. J Card Fail. 2006 Feb; 12(1):1-9. PMID: 16500577.
      View in: PubMed
    116. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005 Dec 20; 112(25):3958-68. PMID: 16365214.
      View in: PubMed
    117. Carson P, Massie BM, McKelvie R, McMurray J, Komajda M, Zile M, Ptaszynska A, Frangin G. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail. 2005 Oct; 11(8):576-85. PMID: 16230259.
      View in: PubMed
    118. Massie BM. Aspirin use in chronic heart failure: what should we recommend to the practitioner? J Am Coll Cardiol. 2005 Sep 20; 46(6):963-6. PMID: 16168276.
      View in: PubMed
    119. Freudenberger RS, Massie BM. Silent cerebral infarction in heart failure: vascular or thromboembolic? J Card Fail. 2005 Sep; 11(7):490-1. PMID: 16198242.
      View in: PubMed
    120. Massie BM, Fabi MR. Clinical trials in diastolic heart failure. Prog Cardiovasc Dis. 2005 May-Jun; 47(6):389-95. PMID: 16115518.
      View in: PubMed
    121. Massie BM. Heart failure trials: are they becoming impractical? J Card Fail. 2005 Apr; 11(3):161-3. PMID: 15812741.
      View in: PubMed
    122. Teerlink JR, Massie BM. Nesiritide and worsening of renal function: the emperor's new clothes? Circulation. 2005 Mar 29; 111(12):1459-61. PMID: 15795361.
      View in: PubMed
    123. Massie BM. Isosorbide dinitrate plus hydralazine was effective for advanced heart failure in black patients. ACP J Club. 2005 Mar-Apr; 142(2):37. PMID: 15739984.
      View in: PubMed
    124. Massie BM. The year in heart failure: 2004. J Card Fail. 2005 Feb; 11(1):1-6. PMID: 15704055.
      View in: PubMed
    125. Packer M, McMurray J, Massie BM, Caspi A, Charlon V, Cohen-Solal A, Kiowski W, Kostuk W, Krum H, Levine B, Rizzon P, Soler J, Swedberg K, Anderson S, Demets DL. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail. 2005 Feb; 11(1):12-20. PMID: 15704058.
      View in: PubMed
    126. Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF, Gheorghiade M, O'Connor CM. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004 Dec; 10(6):460-6. PMID: 15599835.
      View in: PubMed
    127. Massie BM. Should the management of heart failure become a new subspecialty? J Card Fail. 2004 Oct; 10(5):363-5. PMID: 15470643.
      View in: PubMed
    128. Franciosa JA, Massie BM, Lukas MA, Nelson JJ, Lottes S, Abraham WT, Fowler M, Gilbert EM, Greenberg B. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry. Am Heart J. 2004 Oct; 148(4):718-26. PMID: 15459606.
      View in: PubMed
    129. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation. 2004 Sep 21; 110(12):1514-7. PMID: 15381655.
      View in: PubMed
    130. Hlatky MA, Massie BM. Cardiac resynchronization for heart failure. Ann Intern Med. 2004 Sep 07; 141(5):399-400. PMID: 15313731.
      View in: PubMed
    131. Shlipak MG, Smith GL, Rathore SS, Massie BM, Krumholz HM. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol. 2004 Aug; 15(8):2195-203. PMID: 15284305.
      View in: PubMed
    132. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study. Am J Med. 2004 Apr 15; 116(8):509-16. PMID: 15063811; PMCID: PMC2776680.
    133. Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004 Apr; 10(2):101-12. PMID: 15101020.
      View in: PubMed
    134. Massie BM. 2003: The year in heart failure. J Card Fail. 2004 Feb; 10(1):1-3. PMID: 14966766.
      View in: PubMed
    135. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004 Feb; 147(2):331-8. PMID: 14760333.
      View in: PubMed
    136. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004 Jan 07; 43(1):61-7. PMID: 14715185.
      View in: PubMed
    137. Ansari M, Araoz PA, Gerard SK, Watzinger N, Lund GK, Massie BM, Higgins CB, Saloner DA. Comparison of late enhancement cardiovascular magnetic resonance and thallium SPECT in patients with coronary disease and left ventricular dysfunction. J Cardiovasc Magn Reson. 2004; 6(2):549-56. PMID: 15137339.
      View in: PubMed
    138. DeMets DL, Fleming TR, Rockhold F, Massie B, Merchant T, Meisel A, Mishkin B, Wittes J, Stump D, Califf R. Liability issues for data monitoring committee members. Clin Trials. 2004; 1(6):525-31. PMID: 16279293.
      View in: PubMed
    139. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation. 2003 Dec 16; 108(24):2987-92. PMID: 14662720; PMCID: PMC2771188.
    140. Massie BM. A comment on COMET: how to interpret a positive trial? J Card Fail. 2003 Dec; 9(6):425-8. PMID: 14966781.
      View in: PubMed
    141. Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail. 2003 Oct; 9(5):354-63. PMID: 14583895.
      View in: PubMed
    142. Massie BM. The dilemma of drug development for heart failure: when is the time to initiate large clinical trials? J Card Fail. 2003 Oct; 9(5):347-9. PMID: 14583893.
      View in: PubMed
    143. Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie BM, McNamara DM, Oren R, Rogers WJ. Failure of benefit and early hazard of bucindolol for Class IV heart failure. J Card Fail. 2003 Aug; 9(4):266-77. PMID: 13680547.
      View in: PubMed
    144. Havranek EP, Krumholz HM, Dudley RA, Adams K, Gregory D, Lampert S, Lindenfeld J, Massie BM, Pina I, Restaino S, Rich MW, Konstam MA. Aligning quality and payment for heart failure care: defining the challenges. J Card Fail. 2003 Aug; 9(4):251-4. PMID: 13680543.
      View in: PubMed
    145. Ansari M, Massie BM. Heart failure: how big is the problem? Who are the patients? What does the future hold? Am Heart J. 2003 Jul; 146(1):1-4. PMID: 12851600.
      View in: PubMed
    146. Ansari M, Alexander M, Tutar A, Massie BM. Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic function. Am Heart J. 2003 Jul; 146(1):115-20. PMID: 12851618.
      View in: PubMed
    147. Massie BM. Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure: good news and bad. J Am Coll Cardiol. 2003 Jun 04; 41(11):2018-21. PMID: 12798575.
      View in: PubMed
    148. Teerlink JR, Massie BM. Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION. J Card Fail. 2003 Jun; 9(3):158-63. PMID: 12815564.
      View in: PubMed
    149. Ansari M, Shlipak MG, Heidenreich PA, Van Ostaeyen D, Pohl EC, Browner WS, Massie BM. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation. 2003 Jun 10; 107(22):2799-804. PMID: 12756157.
      View in: PubMed
    150. Massie BM. Negative, neutral, and discordant results: what should an editor do? J Card Fail. 2003 Apr; 9(2):77-9. PMID: 12751126.
      View in: PubMed
    151. Massie BM, Ansari MN. Specialty care for heart failure: does it improve outcomes? Am Heart J. 2003 Feb; 145(2):209-13. PMID: 12595835.
      View in: PubMed
    152. Shlipak MG, Chertow GC, Massie BM. Beware the rising creatinine level. J Card Fail. 2003 Feb; 9(1):26-8. PMID: 12612869.
      View in: PubMed
    153. Jain P, Massie BM, Gattis WA, Klein L, Gheorghiade M. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. Am Heart J. 2003 Feb; 145(2 Suppl):S3-17. PMID: 12594447.
      View in: PubMed
    154. Ansari M, Alexander M, Tutar A, Bello D, Massie BM. Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol. 2003 Jan 01; 41(1):62-8. PMID: 12570946.
      View in: PubMed
    155. Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Rydén L. Mode of death in heart failure: findings from the ATLAS trial. Heart. 2003 Jan; 89(1):42-8. PMID: 12482789; PMCID: PMC1767481.
    156. Massie BM. What is the significance of a journal's impact factor? J Card Fail. 2002 Dec; 8(6):363-4. PMID: 12528086.
      View in: PubMed
    157. Massie BM. What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians. J Card Fail. 2002 Aug; 8(4):197-201. PMID: 12397565.
      View in: PubMed
    158. Massie BM. Obesity and heart failure--risk factor or mechanism? N Engl J Med. 2002 Aug 01; 347(5):358-9. PMID: 12151474.
      View in: PubMed
    159. Massie BM. Treating heart failure: it's time for new paradigms and novel approaches. J Card Fail. 2002 Jun; 8(3):117-9. PMID: 12140801.
      View in: PubMed
    160. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002 Jun; 8(3):136-41. PMID: 12140805.
      View in: PubMed
    161. Massie BM. Comment--LVADs as long-term cardiac replacement: Success but on what terms and at what cost? J Card Fail. 2002 Apr; 8(2):61-2. PMID: 12016627.
      View in: PubMed
    162. Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002 Mar 27; 287(12):1541-7. PMID: 11911756.
      View in: PubMed
    163. Massie BM. Neurohormonal blockade in chronic heart failure. How much is enough? Can there be too much?. J Am Coll Cardiol. 2002 Jan 02; 39(1):79-82. PMID: 11755290.
      View in: PubMed
    164. Dauterman KW, Go AS, Rowell R, Gebretsadik T, Gettner S, Massie BM. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail. 2001 Sep; 7(3):221-8. PMID: 11561221.
      View in: PubMed
    165. Leier CV, Silver MA, Massie BM, Young JB, Fowler MB, Ventura HO, Hershberger RE. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 1--the medical history. Congest Heart Fail. 2001 Sep-Oct; 7(5):245-249. PMID: 11832662.
      View in: PubMed
    166. Cleland JG, Thygesen K, Uretsky BF, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Rydén L. Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J. 2001 Sep; 22(17):1601-12. PMID: 11492990.
      View in: PubMed
    167. Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med. 2001 Apr 15; 110(6):425-33. PMID: 11331052.
      View in: PubMed
    168. Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA, Rydén L. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. Arch Intern Med. 2001 Jan 22; 161(2):165-71. PMID: 11176729.
      View in: PubMed
    169. Rydén L, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J. 2000 Dec; 21(23):1967-78. PMID: 11071803.
      View in: PubMed
    170. Sculpher MJ, Poole L, Cleland J, Drummond M, Armstrong PW, Horowitz JD, Massie BM, Poole-Wilson PA, Ryden L. Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group. Eur J Heart Fail. 2000 Dec; 2(4):447-54. PMID: 11113723.
      View in: PubMed
    171. Massie BM, Teerlink JR. Interaction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined. Am J Med. 2000 Oct 01; 109(5):431-3. PMID: 11020401.
      View in: PubMed
    172. Frances CD, Noguchi H, Massie BM, Browner WS, McClellan M. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. Arch Intern Med. 2000 Sep 25; 160(17):2645-50. PMID: 10999979.
      View in: PubMed
    173. Gabai VL, Yaglom JA, Volloch V, Meriin AB, Force T, Koutroumanis M, Massie B, Mosser DD, Sherman MY. Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol Cell Biol. 2000 Sep; 20(18):6826-36. PMID: 10958679; PMCID: PMC86215.
    174. Franciosa JA, Abraham WT, Fowler M, Gilbert EM, Greenberg B, Massie BM, Chen T, Lukas MA, Nelson JJ. Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians. J Card Fail. 2000 Sep; 6(3):264-71. PMID: 10997754.
      View in: PubMed
    175. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA, Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation. 2000 Aug 08; 102(6):611-6. PMID: 10931799.
      View in: PubMed
    176. Hou ST, Callaghan D, Fournier MC, Hill I, Kang L, Massie B, Morley P, Murray C, Rasquinha I, Slack R, MacManus JP. The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem. 2000 Jul; 75(1):91-100. PMID: 10854251.
      View in: PubMed
    177. Ashton CM, Bozkurt B, Colucci WB, Kiefe CI, Mann DL, Massie BM, Slawsky MT, Tierney WM, West JA, Whellan DJ, Wray NP. Veterans Affairs Quality Enhancement Research Initiative in chronic heart failure. Med Care. 2000 Jun; 38(6 Suppl 1):I26-37. PMID: 10843268.
      View in: PubMed
    178. Teerlink JR, Massie BM. The role of beta-blockers in preventing sudden death in heart failure. J Card Fail. 2000 Jun; 6(2 Suppl 1):25-33. PMID: 10908095.
      View in: PubMed
    179. Cho WK, Ebihara S, Nalbantoglu J, Gilbert R, Massie B, Holland P, Karpati G, Petrof BJ. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther. 2000 Mar 20; 11(5):701-14. PMID: 10757350.
      View in: PubMed
    180. Go AS, Rao RK, Dauterman KW, Massie BM. A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States. Am J Med. 2000 Feb 15; 108(3):216-26. PMID: 10723976.
      View in: PubMed
    181. Cuffe MS, Califf RM, Adams KF, Bourge RC, Colucci W, Massie B, O'Connor CM, Pina I, Quigg R, Silver M, Robinson LA, Leimberger JD, Gheorghiade M. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. Am Heart J. 2000 Jan; 139(1 Pt 1):15-22. PMID: 10618557.
      View in: PubMed
    182. Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G, Packer M, Massie BM. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation. 2000 Jan 4-11; 101(1):40-6. PMID: 10618302.
      View in: PubMed
    183. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Rydén L, Thygesen K, Uretsky BF. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999 Dec 07; 100(23):2312-8. PMID: 10587334.
      View in: PubMed
    184. O'Connor CM, Gattis WA, Gheorghiade M, Granger CB, Gilbert J, McKenney JM, Messineo FC, Burnett JC, Katz SD, Elkayam U, Kasper EK, Goldstein S, Cody RJ, Massie BM. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study. Am Heart J. 1999 Dec; 138(6 Pt 1):1140-8. PMID: 10577446.
      View in: PubMed
    185. Alexander M, Tekawa I, Hunkeler E, Fireman B, Rowell R, Selby JV, Massie BM, Cooper W. Evaluating hypertension control in a managed care setting. Arch Intern Med. 1999 Dec 13-27; 159(22):2673-7. PMID: 10597757.
      View in: PubMed
    186. Teerlink JR, Massie BM. Beta-adrenergic blocker mortality trials in congestive heart failure. Am J Cardiol. 1999 Nov 04; 84(9A):94R-102R. PMID: 10568667.
      View in: PubMed
    187. Baker DW, Hayes RP, Massie BM, Craig CA. Variations in family physicians' and cardiologists' care for patients with heart failure. Am Heart J. 1999 Nov; 138(5 Pt 1):826-34. PMID: 10539812.
      View in: PubMed
    188. Heidenreich PA, Ruggerio CM, Massie BM. Effect of a home monitoring system on hospitalization and resource use for patients with heart failure. Am Heart J. 1999 Oct; 138(4 Pt 1):633-40. PMID: 10502207.
      View in: PubMed
    189. Teerlink JR, Massie BM. The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers. Am Heart J. 1999 Aug; 138(2 Pt 1):193-7. PMID: 10426826.
      View in: PubMed
    190. Frances CD, Go AS, Dauterman KW, Deosaransingh K, Jung DL, Gettner S, Newman JM, Massie BM, Browner WS. Outcome following acute myocardial infarction: are differences among physician specialties the result of quality of care or case mix? Arch Intern Med. 1999 Jul 12; 159(13):1429-36. PMID: 10399894.
      View in: PubMed
    191. Bello D, Shah NB, Edep ME, Tateo IM, Massie BM. Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure. Am Heart J. 1999 Jul; 138(1 Pt 1):100-7. PMID: 10385771.
      View in: PubMed
    192. Alexander M, Grumbach K, Remy L, Rowell R, Massie BM. Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. Am Heart J. 1999 May; 137(5):919-27. PMID: 10220642.
      View in: PubMed
    193. Cleland JG, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Rydén L. Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study. Eur J Heart Fail. 1999 Mar; 1(1):73-9. PMID: 10937983.
      View in: PubMed
    194. Simonini A, Chang K, Yue P, Long CS, Massie BM. Expression of skeletal muscle sarcoplasmic reticulum calcium-ATPase is reduced in rats with postinfarction heart failure. Heart. 1999 Mar; 81(3):303-7. PMID: 10026358; PMCID: PMC1728966.
    195. Cleland JG, Massie BM, Packer M. Sudden death in heart failure: vascular or electrical? Eur J Heart Fail. 1999 Mar; 1(1):41-5. PMID: 10937978.
      View in: PubMed
    196. Mansoor GA, Massie BM. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure. Blood Press Monit. 1999; 4 Suppl 1:S19-22. PMID: 10822413.
      View in: PubMed
    197. Massie BM. The safety of calcium-channel blockers. Clin Cardiol. 1998 Dec; 21(12 Suppl 2):II12-7. PMID: 9853194.
      View in: PubMed
    198. Bello D, Massie BM. The current role of amiodarone in patients with congestive heart failure. Cleve Clin J Med. 1998 Oct; 65(9):479-89. PMID: 9795489.
      View in: PubMed
    199. Massie BM. Clinical trials in heart failure: can we expect the results to be replicated in clinical practice? J Card Fail. 1998 Sep; 4(3):243-7. PMID: 9754598.
      View in: PubMed
    200. Massie BM. 15 years of heart-failure trials: what have we learned? Lancet. 1998 Aug; 352 Suppl 1:SI29-33. PMID: 9736477.
      View in: PubMed
    201. Mardassi H, Gonin P, Gagnon CA, Massie B, Dea S. A subset of porcine reproductive and respiratory syndrome virus GP3 glycoprotein is released into the culture medium of cells as a non-virion-associated and membrane-free (soluble) form. J Virol. 1998 Aug; 72(8):6298-306. PMID: 9658068; PMCID: PMC109768.
    202. Yue P, Long CS, Austin R, Chang KC, Simpson PC, Massie BM. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. J Mol Cell Cardiol. 1998 Aug; 30(8):1615-30. PMID: 9737947.
      View in: PubMed
    203. Yue P, Massie BM, Simpson PC, Long CS. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol. 1998 Jul; 275(1 Pt 2):H250-8. PMID: 9688921.
      View in: PubMed
    204. Dauterman KW, Massie BM, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J. 1998 Jun; 135(6 Pt 2 Su):S310-9. PMID: 9630093.
      View in: PubMed
    205. Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: a management algorithm. Am Heart J. 1998 Jun; 135(6 Pt 2 Su):S293-309. PMID: 9630092.
      View in: PubMed
    206. Massie BM. Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris. Am J Hypertens. 1998 Apr; 11(4 Pt 3):95S-102S. PMID: 9607373.
      View in: PubMed
    207. Howell JM, Lochmüller H, O'Hara A, Fletcher S, Kakulas BA, Massie B, Nalbantoglu J, Karpati G. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Hum Gene Ther. 1998 Mar 20; 9(5):629-34. PMID: 9551611.
      View in: PubMed
    208. Massie BM, Cleland JG, Armstrong PW, Horowitz JD, Packer M, Poole-Wilson PA, Ryden L, Lars R. Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators. J Card Fail. 1998 Mar; 4(1):3-8. PMID: 9573498.
      View in: PubMed
    209. Shah NB, Der E, Ruggerio C, Heidenreich PA, Massie BM. Prevention of hospitalizations for heart failure with an interactive home monitoring program. Am Heart J. 1998 Mar; 135(3):373-8. PMID: 9506321.
      View in: PubMed
    210. Massie BM, Abdalla I. Heart failure in patients with preserved left ventricular systolic function: do digitalis glycosides have a role? Prog Cardiovasc Dis. 1998 Jan-Feb; 40(4):357-69. PMID: 9449960.
      View in: PubMed
    211. Massie BM. Mibefradil: a selective T-type calcium antagonist. Am J Cardiol. 1997 Nov 06; 80(9A):23I-32I. PMID: 9375939.
      View in: PubMed
    212. Massie BM. News from the FDA Cardio-renal Advisory Committee meeting of June 26, 1997. Circulation. 1997 Oct 21; 96(8):2483. PMID: 9355877.
      View in: PubMed
    213. Massie BM, Lacourcière Y, Viskoper R, Woittiez A, Kobrin I. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists. Am J Cardiol. 1997 Aug 21; 80(4B):27C-33C. PMID: 9286851.
      View in: PubMed
    214. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997 Aug; 30(2):518-26. PMID: 9247527.
      View in: PubMed
    215. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997 Jul; 30(1):27-34. PMID: 9207617.
      View in: PubMed
    216. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997 Jun; 133(6):703-12. PMID: 9200399.
      View in: PubMed
    217. Massie BM, Chrysant SG, Jain A, Weir M, Weiss R, Korrin I. Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD. Clin Cardiol. 1997 Jun; 20(6):562-8. PMID: 9181268.
      View in: PubMed
    218. Massie BM. Heart failure 1997: a time to take stock. Curr Opin Cardiol. 1997 May; 12(3):209-17. PMID: 9243077.
      View in: PubMed
    219. Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation. 1997 Apr 15; 95(8):2007-14. PMID: 9133508.
      View in: PubMed
    220. Massie BM. Analyses of cost effectiveness in the management of essential hypertension: what they can and what they do not teach us. Clin Cardiol. 1996 Oct; 19(10):810-6. PMID: 8896914.
      View in: PubMed
    221. Simonini A, Massie BM, Long CS, Qi M, Samarel AM. Alterations in skeletal muscle gene expression in the rat with chronic congestive heart failure. J Mol Cell Cardiol. 1996 Aug; 28(8):1683-91. PMID: 8877778.
      View in: PubMed
    222. Mardassi H, Massie B, Dea S. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology. 1996 Jul 01; 221(1):98-112. PMID: 8661418.
      View in: PubMed
    223. Massie BM, Shah NB, Pitt B, Packer M. Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: experience from trials of flosequinan. Am Heart J. 1996 Jul; 132(1 Pt 1):130-6. PMID: 8701855.
      View in: PubMed
    224. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res. 1996 Jul; 79(1):128-36. PMID: 8925560.
      View in: PubMed
    225. Massie BM, Fisher SG, Radford M, Deedwania PC, Singh BN, Fletcher RD, Singh SN. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation. 1996 Jun 15; 93(12):2128-34. PMID: 8925581.
      View in: PubMed
    226. Massie BM, Shah NB. The heart failure epidemic: magnitude of the problem and potential mitigating approaches. Curr Opin Cardiol. 1996 May; 11(3):221-6. PMID: 8835863.
      View in: PubMed
    227. Paquet L, Massie B, Mains RE. Proneuropeptide Y processing in large dense-core vesicles: manipulation of prohormone convertase expression in sympathetic neurons using adenoviruses. J Neurosci. 1996 Feb 01; 16(3):964-73. PMID: 8558265.
      View in: PubMed
    228. Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol. 1996 Jan; 27(1):140-5. PMID: 8522687.
      View in: PubMed
    229. Petrof BJ, Acsadi G, Jani A, Massie B, Bourdon J, Matusiewicz N, Yang L, Lochmüller H, Karpati G. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am J Respir Cell Mol Biol. 1995 Nov; 13(5):508-17. PMID: 7576685.
      View in: PubMed
    230. Yamani MH, Wells L, Massie BM, Ammon S, Der E, Prouty K. Relation of the nine-minute self-powered treadmill test to maximal exercise capacity and skeletal muscle function in patients with congestive heart failure. Am J Cardiol. 1995 Oct 15; 76(11):788-92. PMID: 7572656.
      View in: PubMed
    231. Materson BJ, Reda DJ, Preston RA, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med. 1995 Sep 11; 155(16):1757-62. PMID: 7654109.
      View in: PubMed
    232. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995 Jul 13; 333(2):77-82. PMID: 7539890.
      View in: PubMed
    233. Massie BM, Shah NB. Future approaches to pharmacologic therapy for congestive heart failure. Curr Opin Cardiol. 1995 May; 10(3):229-37. PMID: 7612971.
      View in: PubMed
    234. Yamani MH, Sahgal P, Wells L, Massie BM. Exercise intolerance in chronic heart failure is not associated with impaired recovery of muscle function or submaximal exercise performance. J Am Coll Cardiol. 1995 May; 25(6):1232-8. PMID: 7722115.
      View in: PubMed
    235. Massie BM, Schaefer S, Garcia J, McKirnan MD, Schwartz GG, Wisneski JA, Weiner MW, White FC. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation. 1995 Mar 15; 91(6):1814-23. PMID: 7882492.
      View in: PubMed
    236. Huard J, Lochmüller H, Acsadi G, Jani A, Massie B, Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 1995 Mar; 2(2):107-15. PMID: 7719927.
      View in: PubMed
    237. Schaefer S, Schwartz GG, Steinman S, Garcia J, Trocha SD, Weiner MW, Massie BM. Effects of regional myocardial lidocaine infusion on high energy phosphates. J Mol Cell Cardiol. 1994 Dec; 26(12):1601-11. PMID: 7731055.
      View in: PubMed
    238. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994 Nov 16; 272(19):1528-34. PMID: 7966846.
      View in: PubMed
    239. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, Williams DW, Henderson WG. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol. 1994 Nov 15; 24(6):1492-8. PMID: 7930281.
      View in: PubMed
    240. Dracup K, Baker DW, Dunbar SB, Dacey RA, Brooks NH, Johnson JC, Oken C, Massie BM. Management of heart failure. II. Counseling, education, and lifestyle modifications. JAMA. 1994 Nov 09; 272(18):1442-6. PMID: 7933427.
      View in: PubMed
    241. Chou TM, Sweeney JP, Massie BM. Marked T-wave inversion after internal jugular cannulation complicated by neck hematoma. Am Heart J. 1994 Nov; 128(5):1038-40. PMID: 7942467.
      View in: PubMed
    242. Yamani MH, Massie BM. Hypertension, myocardial ischemia, and sudden death. Curr Opin Cardiol. 1994 Sep; 9(5):542-50. PMID: 7987033.
      View in: PubMed
    243. Massie BM. A personal perspective on the treatment of heart failure in 1994. Curr Opin Cardiol. 1994 May; 9(3):255-63. PMID: 8049583.
      View in: PubMed
    244. Massie BM. First-line therapy for hypertension: different patients, different needs. Geriatrics. 1994 Apr; 49(4):22-30. PMID: 7909305.
      View in: PubMed
    245. Alkhatib G, Shen SH, Briedis D, Richardson C, Massie B, Weinberg R, Smith D, Taylor J, Paoletti E, Roder J. Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors. J Virol. 1994 Mar; 68(3):1522-31. PMID: 8107215; PMCID: PMC236609.
    246. Massie BM, Schwartz GG, Garcia J, Wisneski JA, Weiner MW, Owens T. Myocardial metabolism during increased work states in the porcine left ventricle in vivo. Circ Res. 1994 Jan; 74(1):64-73. PMID: 8261596.
      View in: PubMed
    247. Yamani M, Massie BM. Congestive heart failure: insights from epidemiology, implications for treatment. Mayo Clin Proc. 1993 Dec; 68(12):1214-8. PMID: 8246628.
      View in: PubMed
    248. Singh SN, Fletcher RD, Fisher S, Lazzeri D, Deedwania P, Lewis D, Massie B, Singh BN, Colling C. Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators. Am J Cardiol. 1993 Nov 26; 72(16):99F-102F. PMID: 8237838.
      View in: PubMed
    249. Massie BM, Szlachcic Y, Tubau JF, O'Kelly BF, Ammon S, Chin W. Scintigraphic and electrocardiographic evidence of silent coronary artery disease in asymptomatic hypertension: a case-control study. J Am Coll Cardiol. 1993 Nov 15; 22(6):1598-606. PMID: 8227826.
      View in: PubMed
    250. Massie BM, Berk MR, Brozena SC, Elkayam U, Plehn JF, Kukin ML, Packer M, Murphy BE, Neuberg GW, Steingart RM. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET). Circulation. 1993 Aug; 88(2):492-501. PMID: 8339411.
      View in: PubMed
    251. Packer M, Narahara KA, Elkayam U, Sullivan JM, Pearle DL, Massie BM, Creager MA. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study. J Am Coll Cardiol. 1993 Jul; 22(1):65-72. PMID: 8509565.
      View in: PubMed
    252. Minotti JR, Pillay P, Oka R, Wells L, Christoph I, Massie BM. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol (1985). 1993 Jul; 75(1):373-81. PMID: 8376288.
      View in: PubMed
    253. Massie BM, Mangano DT. Assessment of perioperative risk: have we put the cart before the horse. J Am Coll Cardiol. 1993 May; 21(6):1353-6. PMID: 8473641.
      View in: PubMed
    254. Massie BM, Mangano DT. Risk stratification for noncardiac surgery. How (and why)? Circulation. 1993 May; 87(5):1752-5. PMID: 8491030.
      View in: PubMed
    255. Figueredo VM, Brandes R, Weiner MW, Massie BM, Camacho SA. Endocardial versus epicardial differences of intracellular free calcium under normal and ischemic conditions in perfused rat hearts. Circ Res. 1993 May; 72(5):1082-90. PMID: 8477520.
      View in: PubMed
    256. Massie BM, Rothenberg D. Publication of sponsored symposiums in medical journals. N Engl J Med. 1993 Apr 22; 328(16):1196-7; author reply 1197-8. PMID: 8455690.
      View in: PubMed
    257. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993 Apr 01; 328(13):914-21. PMID: 8446138.
      View in: PubMed
    258. Kent-Braun JA, Sharma KR, Weiner MW, Massie B, Miller RG. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology. 1993 Jan; 43(1):125-31. PMID: 8423875.
      View in: PubMed
    259. Degroot M, Massie BM, Boska M, Gober J, Miller RG, Weiner MW. Dissociation of [H+] from fatigue in human muscle detected by high time resolution 31P-NMR. Muscle Nerve. 1993 Jan; 16(1):91-8. PMID: 8423837.
      View in: PubMed
    260. Massie B. Angiotensin-converting enzyme inhibitors as cardioprotective agents. Am J Cardiol. 1992 Dec 21; 70(21):10I-17I. PMID: 1471600.
      View in: PubMed
    261. Massie B. Effect of diuretic therapy on hypertensive left ventricular hypertrophy. Eur Heart J. 1992 Dec; 13 Suppl G:53-60. PMID: 1486907.
      View in: PubMed
    262. Figueredo VM, Brandes R, Weiner MW, Massie B, Camacho SA. Cardiac contractile dysfunction during mild coronary flow reductions is due to an altered calcium-pressure relationship in rat hearts. J Clin Invest. 1992 Nov; 90(5):1794-802. PMID: 1430205; PMCID: PMC443238.
    263. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B. The heart in hypertension. N Engl J Med. 1992 Oct 01; 327(14):998-1008. PMID: 1518549.
      View in: PubMed
    264. Schwartz GG, Schaefer S, Trocha SD, Garcia J, Steinman S, Massie B, Weiner MW. Effect of supranormal coronary blood flow on energy metabolism and systolic function of porcine left ventricle. Cardiovasc Res. 1992 Oct; 26(10):1001-6. PMID: 1486583.
      View in: PubMed
    265. Singh S, Fletcher RD, Fisher S, Deedwania P, Lewis D, Massie B, Singh B, Colling CL. Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators. Control Clin Trials. 1992 Oct; 13(5):339-50. PMID: 1385036.
      View in: PubMed
    266. Brandes R, Figueredo VM, Camacho SA, Massie B, Weiner MW. Suppression of motion artifacts in fluorescence spectroscopy of perfused hearts. Am J Physiol. 1992 Sep; 263(3 Pt 2):H972-80. PMID: 1415626.
      View in: PubMed
    267. Minotti JR, Pillay P, Chang L, Wells L, Massie B. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation. 1992 Sep; 86(3):903-8. PMID: 1516203.
      View in: PubMed
    268. Nauman D, Greenberg B, Massie B, Bristow JD, Cheitlin M. Effects of stopping long-term vasodilator therapy in patients with chronic aortic insufficiency. Chest. 1992 Sep; 102(3):720-4. PMID: 1516393.
      View in: PubMed
    269. O'Kelly B, Browner WS, Massie B, Tubau J, Ngo L, Mangano DT. Ventricular arrhythmias in patients undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA. 1992 Jul 08; 268(2):217-21. PMID: 1608140.
      View in: PubMed
    270. Chin WL, O'Kelly B, Tubau JF, Szlachcic J, Brown D, Wisneski JA, Ammon S, Massie B. Diagnostic accuracy of exercise thallium-201 scintigraphy in men with asymptomatic essential hypertension. Am J Hypertens. 1992 Jul; 5(7):465-72. PMID: 1637519.
      View in: PubMed
    271. Schaefer S, Schwartz GG, Steinman SK, Meyerhoff DJ, Massie B, Weiner MW. Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus-31 studies of normal and cardiomyopathic myocardium. Magn Reson Med. 1992 Jun; 25(2):260-72. PMID: 1614310.
      View in: PubMed
    272. Minotti JR, Massie B. Exercise training in heart failure patients. Does reversing the peripheral abnormalities protect the heart? Circulation. 1992 Jun; 85(6):2323-5. PMID: 1591849.
      View in: PubMed
    273. Minotti JR, Christoph I, Massie B. Skeletal muscle function, morphology, and metabolism in patients with congestive heart failure. Chest. 1992 May; 101(5 Suppl):333S-339S. PMID: 1576861.
      View in: PubMed
    274. Massie B, Der E, Herman TS, Topolski P, Park GD, Stewart WH. 24-hour efficacy of once-daily diltiazem in essential hypertension. Clin Cardiol. 1992 May; 15(5):365-8. PMID: 1623657.
      View in: PubMed
    275. Szlachcic J, Tubau JF, O'Kelly B, Ammon S, Daiss K, Massie B. What is the role of silent coronary artery disease and left ventricular hypertrophy in the genesis of ventricular arrhythmias in men with essential hypertension? J Am Coll Cardiol. 1992 Mar 15; 19(4):803-8. PMID: 1531991.
      View in: PubMed
    276. Wilson RA, McDonald RW, Bristow JD, Cheitlin M, Nauman D, Massie B, Greenberg B. Correlates of aortic distensibility in chronic aortic regurgitation and relation to progression to surgery. J Am Coll Cardiol. 1992 Mar 15; 19(4):733-8. PMID: 1545067.
      View in: PubMed
    277. Schwartz GG, Steinman S, Garcia J, Greyson C, Massie B, Weiner MW. Energetics of acute pressure overload of the porcine right ventricle. In vivo 31P nuclear magnetic resonance. J Clin Invest. 1992 Mar; 89(3):909-18. PMID: 1541681; PMCID: PMC442937.
    278. Schaefer S, Schwartz GG, Wisneski JA, Trocha SD, Christoph I, Steinman SK, Garcia J, Massie B, Weiner MW. Response of high-energy phosphates and lactate release during prolonged regional ischemia in vivo. Circulation. 1992 Jan; 85(1):342-9. PMID: 1728466.
      View in: PubMed
    279. Minotti JR, Christoph I, Oka R, Weiner MW, Wells L, Massie B. Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J Clin Invest. 1991 Dec; 88(6):2077-82. PMID: 1752965; PMCID: PMC295805.
    280. Haeusslein EA, Greenberg BH, Massie B. Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilation in chronic congestive heart failure? Chest. 1991 Nov; 100(5):1312-5. PMID: 1935287.
      View in: PubMed
    281. Mangano DT, Massie B, Browner WS. The dipyridamole-thallium test. Circulation. 1991 Oct; 84(4):1879-80. PMID: 1914126.
      View in: PubMed
    282. Wilson R, Perlmutter N, Jacobson N, Siemienczuk D, Szlachcic J, Bristow JD, Cheitlin M, Massie B, Greenberg B. Effects of long-term vasodilator therapy on electrocardiographic abnormalities in chronic aortic regurgitation. Am J Cardiol. 1991 Oct 01; 68(9):935-9. PMID: 1927953.
      View in: PubMed
    283. Schwartz GG, Schaefer S, Trocha SD, Steinman S, Gober J, Garcia J, Massie B, Weiner MW. Metabolic and functional consequences of blunted myocardial reactive hyperemia. Am J Physiol. 1991 Sep; 261(3 Pt 2):H892-900. PMID: 1887933.
      View in: PubMed
    284. Mangano DT, London MJ, Tubau JF, Browner WS, Hollenberg M, Krupski W, Layug EL, Massie B. Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group. Circulation. 1991 Aug; 84(2):493-502. PMID: 1860194.
      View in: PubMed
    285. Gober JR, Schwartz GG, Schaefer S, Massie B, Matson GB, Weiner MW, Karczmar GS. 31P MRS of myocardial inorganic phosphate using radiofrequency gradient echoes. Magn Reson Med. 1991 Aug; 20(2):171-83. PMID: 1775045.
      View in: PubMed
    286. Szlachcic J, Tubau JF, O'Kelly B, Ammon S, Massie BM. Influence of therapy on silent ischemia and ventricular arrhythmias in hypertensive patients. J Cardiovasc Pharmacol. 1991; 18 Suppl 1:S106-8. PMID: 1723447.
      View in: PubMed
    287. Schwartz GG, Schaefer S, Gober J, Meyerhoff DJ, Smekal A, Massie B, Weiner MW. Myocardial high-energy phosphates in reactive hyperemia. Am J Physiol. 1990 Oct; 259(4 Pt 2):H1190-6. PMID: 2221125.
      View in: PubMed
    288. Minotti JR, Johnson EC, Hudson TL, Zuroske G, Murata G, Fukushima E, Cagle TG, Chick TW, Massie B, Icenogle MV. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest. 1990 Sep; 86(3):751-8. PMID: 2394829; PMCID: PMC296789.
    289. Massie B. All patients with left ventricular systolic dysfunction should be treated with an angiotensin-converting enzyme inhibitor: a protagonist's viewpoint. Am J Cardiol. 1990 Aug 15; 66(4):439-43. PMID: 2201178.
      View in: PubMed
    290. Szlachcic J, Tubau JF, O'Kelly B, Massie B. Correlates of diastolic filling abnormalities in hypertension: a Doppler echocardiographic study. Am Heart J. 1990 Aug; 120(2):386-91. PMID: 2382616.
      View in: PubMed
    291. Schwartz GG, Schaefer S, Meyerhoff DJ, Gober J, Fochler P, Massie B, Weiner MW. Dynamic relation between myocardial contractility and energy metabolism during and following brief coronary occlusion in the pig. Circ Res. 1990 Aug; 67(2):490-500. PMID: 2376083.
      View in: PubMed
    292. Schaefer S, Gober JR, Schwartz GG, Twieg DB, Weiner MW, Massie B. In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol. 1990 May 01; 65(16):1154-61. PMID: 2139540.
      View in: PubMed
    293. Szlachcic J, Hall WD, Tubau JF, Porter V, Vollmer C, Wollam G, Hirsch A, Massie B. Left ventricular hypertrophy reversal with labetalol and propranolol: a prospective randomized, double-blind study. Cardiovasc Drugs Ther. 1990 Apr; 4(2):427-33. PMID: 2149513.
      View in: PubMed
    294. Schaefer S, Schwartz GG, Gober JR, Wong AK, Camacho SA, Massie B, Weiner MW. Relationship between myocardial metabolites and contractile abnormalities during graded regional ischemia. Phosphorus-31 nuclear magnetic resonance studies of porcine myocardium in vivo. J Clin Invest. 1990 Mar; 85(3):706-13. PMID: 2312722; PMCID: PMC296486.
    295. Gober JR, Schaefer S, Camacho SA, DeGroot M, Obregon R, Botvinick EH, Weiner M, Massie B. Epicardial and endocardial localized 31P magnetic resonance spectroscopy: evidence for metabolic heterogeneity during regional ischemia. Magn Reson Med. 1990 Feb; 13(2):204-15. PMID: 2314211.
      View in: PubMed
    296. Massie B. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators? Cardiovasc Clin. 1990; 21(1):251-62; discussion 263-4. PMID: 2199051.
      View in: PubMed
    297. Schaefer S, Schwartz GG, Gober JR, Massie B, Weiner MW. Magnetic resonance spectroscopy. Evaluation of ischemic heart disease. Invest Radiol. 1989 Dec; 24(12):969-72. PMID: 2691443.
      View in: PubMed
    298. Weiner MW, Hetherington H, Hubesch B, Karczmar G, Massie B, Maudsley A, Meyerhoff DJ, Sappey-Marinier D, Schaefer S, Twieg DB. Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed. 1989 Dec; 2(5-6):290-7. PMID: 2701809.
      View in: PubMed
    299. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol. 1989 Sep; 14(3):564-70; discussion 571-2. PMID: 2768707.
      View in: PubMed
    300. Schaefer S, Massie B, Weiner MW. Magnetic resonance spectroscopy of the heart. Cardiol Clin. 1989 Aug; 7(3):697-712. PMID: 2670234.
      View in: PubMed
    301. Tubau JF, Szlachcic J, Hollenberg M, Massie B. Usefulness of thallium-201 scintigraphy in predicting the development of angina pectoris in hypertensive patients with left ventricular hypertrophy. Am J Cardiol. 1989 Jul 01; 64(1):45-9. PMID: 2525866.
      View in: PubMed
    302. Tubau JF, Szlachcic J, Braun S, Massie B. Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy. Hypertension. 1989 Jul; 14(1):1-8. PMID: 2525526.
      View in: PubMed
    303. O'Kelly BF, Massie B, Tubau JF, Szlachcic J. Coronary morbidity and mortality, pre-existing silent coronary artery disease, and mild hypertension. Ann Intern Med. 1989 Jun 15; 110(12):1017-26. PMID: 2658710.
      View in: PubMed
    304. Bouchard A, Yock P, Schiller NB, Blumlein S, Botvinick EH, Greenberg B, Cheitlin M, Massie B. Value of color Doppler estimation of regurgitant volume in patients with chronic aortic insufficiency. Am Heart J. 1989 May; 117(5):1099-105. PMID: 2711970.
      View in: PubMed
    305. Schaefer S, Camacho SA, Gober J, Obregon RG, DeGroot MA, Botvinick EH, Massie B, Weiner MW. Response of myocardial metabolites to graded regional ischemia: 31P NMR spectroscopy of porcine myocardium in vivo. Circ Res. 1989 May; 64(5):968-76. PMID: 2706762.
      View in: PubMed
    306. Siemienczuk D, Greenberg B, Morris C, Massie B, Wilson RA, Topic N, Bristow JD, Cheitlin M. Chronic aortic insufficiency: factors associated with progression to aortic valve replacement. Ann Intern Med. 1989 Apr 15; 110(8):587-92. PMID: 2930091.
      View in: PubMed
    307. Szlachcic J, Tubau JF, Vollmer C, Massie B. Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension. Am J Cardiol. 1989 Jan 15; 63(3):198-201. PMID: 2642633.
      View in: PubMed
    308. Massie B, Tubau JF, Szlachcic J, O'Kelly BF. Hypertensive heart disease: the critical role of left ventricular hypertrophy. J Cardiovasc Pharmacol. 1989; 13 Suppl 1:S18-24. PMID: 2468972.
      View in: PubMed
    309. Schaefer S, Gober J, Valenza M, Karczmar GS, Matson GB, Camacho SA, Botvinick EH, Massie B, Weiner MW. Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. J Am Coll Cardiol. 1988 Dec; 12(6):1449-55. PMID: 3192842.
      View in: PubMed
    310. Vandenbossche JL, Massie B, Schiller NB, Karliner JS. Relation of left ventricular shape to volume and mass in patients with minimally symptomatic chronic aortic regurgitation. Am Heart J. 1988 Oct; 116(4):1022-7. PMID: 2972178.
      View in: PubMed
    311. Massie B. Angiotensin-converting enzyme inhibition in mild to moderate congestive heart failure: an evolving approach. Am J Hypertens. 1988 Oct; 1(4 Pt 2):402S-409S. PMID: 3056452.
      View in: PubMed
    312. Wilson RA, Greenberg BH, Massie BM, Bristow JD, Cheitlin M, Siemienczuk D, Krishnamurthy GT, Thomas D. Left ventricular response to submaximal and maximal exercise in asymptomatic aortic regurgitation. Am J Cardiol. 1988 Sep 15; 62(9):606-10. PMID: 3414553.
      View in: PubMed
    313. Rajagopalan B, Conway MA, Massie B, Radda GK. Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure. Am J Cardiol. 1988 Sep 09; 62(8):53E-57E. PMID: 3414538.
      View in: PubMed
    314. Papadakis MA, Massie BM. Appropriateness of digoxin use in medical outpatients. Am J Med. 1988 Sep; 85(3):365-8. PMID: 3414732.
      View in: PubMed
    315. Massie BM, Conway M, Rajagopalan B, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation. 1988 Aug; 78(2):320-6. PMID: 3396168.
      View in: PubMed
    316. Massie B. Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? I. Introduction. J Am Coll Cardiol. 1988 Aug; 12(2):547-50. PMID: 2899098.
      View in: PubMed
    317. Greenberg B, Massie B, Bristow JD, Cheitlin M, Siemienczuk D, Topic N, Wilson RA, Szlachcic J, Thomas D. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Circulation. 1988 Jul; 78(1):92-103. PMID: 3289791.
      View in: PubMed
    318. Giles TD, Massie BM. Role of calcium antagonists as initial pharmacologic monotherapy for systemic hypertension in patients over 60 years of age. Am J Cardiol. 1988 Jun 15; 61(16):13H-17H. PMID: 3289345.
      View in: PubMed
    319. Massie B. New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure. Am J Med. 1988 Apr 15; 84(4A):36-46. PMID: 3064607.
      View in: PubMed
    320. Massie B. Exercise tolerance in congestive heart failure. Role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment. Am J Med. 1988 Mar 11; 84(3A):75-82. PMID: 3064602.
      View in: PubMed
    321. Massie B. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol. J Cardiovasc Pharmacol. 1988; 12 Suppl 4:S55-8. PMID: 2468874.
      View in: PubMed
    322. Massie BM. Demographic considerations in the selection of antihypertensive therapy. Am J Cardiol. 1987 Dec 14; 60(17):121I-126I. PMID: 2891290.
      View in: PubMed
    323. Tubau JF, Szlachcic J, London MJ, Hollenberg M, Mangano D, Massie B. Systemic hypertension, left ventricular hypertrophy and coronary artery disease. Am J Cardiol. 1987 Dec 14; 60(17):23I-28I. PMID: 2961247.
      View in: PubMed
    324. Massie B, Conway M, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G, Rajagopalan B. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation. 1987 Nov; 76(5):1009-19. PMID: 3664989.
      View in: PubMed
    325. Tubau JF, Wikman-Coffelt J, Massie BM, Sievers R, Parmley WW. Improved myocardial efficiency in the working perfused heart of the spontaneously hypertensive rat. Hypertension. 1987 Oct; 10(4):396-403. PMID: 3653968.
      View in: PubMed
    326. Massie BM, Cornyn J, Topic N, Loge D, Podolin RA. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside. Am J Cardiol. 1987 Sep 15; 60(8):647-53. PMID: 3661429.
      View in: PubMed
    327. Massie BM, Conway M, Yonge R, Frostick S, Sleight P, Ledingham J, Radda G, Rajagopalan B. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol. 1987 Aug 01; 60(4):309-15. PMID: 3618489.
      View in: PubMed
    328. Tubau JF, Wikman-Coffelt J, Massie B, Szlachcic J, Parmley WW, Sievers R, Henderson S. Diltiazem prevents hypertrophy progression, preserves systolic function, and normalises myocardial oxygen utilisation in the spontaneously hypertensive rat. Cardiovasc Res. 1987 Aug; 21(8):606-14. PMID: 2965615.
      View in: PubMed
    329. Massie B, MacCarthy EP, Ramanathan KB, Weiss RJ, Anderson M, Eidelson BA, Labreche DG, Tubau JF, Ulep D, Bartels D. Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide. Ann Intern Med. 1987 Aug; 107(2):150-7. PMID: 3300457.
      View in: PubMed
    330. Cornyn JW, Massie BM, Greenberg B, Loge DL, Thomas D, Bristow JD, Cheitlin M, Krishnamurthy G. Reproducibility of rest and exercise left ventricular ejection fraction and volumes in chronic aortic regurgitation. Am J Cardiol. 1987 Jun 01; 59(15):1361-5. PMID: 3591692.
      View in: PubMed
    331. Massie B, Tubau JF, Szlachcic J. Comparative studies of calcium-channel blockers and beta-blockers in essential hypertension: clinical implications. Circulation. 1987 Jun; 75(6 Pt 2):V163-9. PMID: 2882873.
      View in: PubMed
    332. Massie BM, Conway M. Survival of patients with congestive heart failure: past, present, and future prospects. Circulation. 1987 May; 75(5 Pt 2):IV11-9. PMID: 3552298.
      View in: PubMed
    333. Szlachcic J, Hirsch AT, Tubau JF, Vollmer C, Henderson S, Massie BM. Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity. Am J Cardiol. 1987 Feb 15; 59(5):393-9. PMID: 3812308.
      View in: PubMed
    334. Massie BM, Tubau JF, Szlachcic J, Vollmer C. Comparison and additivity of nitrendipine and hydrochlorothiazide in systemic hypertension. Am J Cardiol. 1986 Sep 30; 58(8):16D-19D. PMID: 3532749.
      View in: PubMed
    335. Szlachcic J, Massie BM, Greenberg B, Thomas D, Cheitlin M, Bristow JD. Intertest variability of echocardiographic and chest X-ray measurements: implications for decision making in patients with aortic regurgitation. J Am Coll Cardiol. 1986 Jun; 7(6):1310-7. PMID: 3711487.
      View in: PubMed
    336. Massie B. Updated diagnosis and management of congestive heart failure. Geriatrics. 1986 Mar; 41(3):30-5, 38-42. PMID: 3949161.
      View in: PubMed
    337. Pool PE, Massie BM, Venkataraman K, Hirsch AT, Samant DR, Seagren SC, Gaw J, Salel AF, Tubau JF. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial. Am J Cardiol. 1986 Feb 01; 57(4):212-7. PMID: 3511660.
      View in: PubMed
    338. Cornyn JW, Massie BM, Unverferth DV, Leier CV. Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure. Am J Cardiol. 1986 Feb 01; 57(4):238-41. PMID: 3946214.
      View in: PubMed
    339. Massie B. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers. Am J Cardiol. 1985 Dec 06; 56(16):97H-100H. PMID: 2866709.
      View in: PubMed
    340. Inouye IK, Massie BM, Loge D, Tubau JF. Assessment of left ventricular diastolic filling: comparison of fixed and varying region of interest approaches. Am Heart J. 1985 Oct; 110(4):840-4. PMID: 4050658.
      View in: PubMed
    341. Inouye IK, Hirsch AT, Loge D, Tubau JF, Massie BM. Left ventricular filling is usually normal in uncomplicated coronary disease. Am Heart J. 1985 Aug; 110(2):326-31. PMID: 4025109.
      View in: PubMed
    342. Creager MA, Massie B, Faxon DP, Friedman SD, Kramer BL, Weiner DA, Ryan TJ, Topic N, Melidossian CD. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol. 1985 Jul; 6(1):163-73. PMID: 2989349.
      View in: PubMed
    343. Hollenberg M, Go M, Massie BM, Wisneski JA, Gertz EW. Influence of R-wave amplitude on exercise-induced ST depression: need for a "gain factor" correction when interpreting stress electrocardiograms. Am J Cardiol. 1985 Jul 01; 56(1):13-7. PMID: 4014017.
      View in: PubMed
    344. Massie B, Bourassa M, DiBianco R, Hess M, Konstam M, Likoff M, Packer M. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation. 1985 May; 71(5):963-71. PMID: 3886191.
      View in: PubMed
    345. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985 Apr 01; 55(8):1037-42. PMID: 3984864.
      View in: PubMed
    346. Massie BM, Kramer BL, Loge D, Topic N, Greenberg BH, Cheitlin MD, Bristow JD, Byrd RC. Ejection fraction response to supine exercise in asymptomatic aortic regurgitation: relation to simultaneous hemodynamic measurements. J Am Coll Cardiol. 1985 Apr; 5(4):847-55. PMID: 3973289.
      View in: PubMed
    347. Greenberg B, Massie B, Thomas D, Bristow JD, Cheitlin M, Broudy D, Szlachcic J, Krishnamurthy G. Association between the exercise ejection fraction response and systolic wall stress in patients with chronic aortic insufficiency. Circulation. 1985 Mar; 71(3):458-65. PMID: 2982519.
      View in: PubMed
    348. Vandenbossche JL, Kramer BL, Massie BM, Morris DL, Karliner JS. Two-dimensional echocardiographic evaluation of the size, function and shape of the left ventricle in chronic aortic regurgitation: comparison with radionuclide angiography. J Am Coll Cardiol. 1984 Dec; 4(6):1195-206. PMID: 6094638.
      View in: PubMed
    349. Massie BM, Hirsch AT, Inouye IK, Tubau JF. Calcium channel blockers as antihypertensive agents. Am J Med. 1984 Oct 05; 77(4A):135-42. PMID: 6091447.
      View in: PubMed
    350. Inouye IK, Massie BM, Loge D, Simpson P, Tubau JF. Failure of antihypertensive therapy with diuretic, beta-blocking and calcium channel-blocking drugs to consistently reverse left ventricular diastolic filling abnormalities. Am J Cardiol. 1984 Jun 01; 53(11):1583-7. PMID: 6731303.
      View in: PubMed
    351. Massie BM, Kramer BL, Topic N. Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses. Circulation. 1984 Jun; 69(6):1135-41. PMID: 6370493.
      View in: PubMed
    352. Inouye IK, Massie BM, Benowitz N, Simpson P, Loge D. Antihypertensive therapy with diltiazem and comparison with hydrochlorothiazide. Am J Cardiol. 1984 Jun 01; 53(11):1588-92. PMID: 6375339.
      View in: PubMed
    353. Massie BM, Wisneski JA, Hollenberg M, Gertz EW, Henderson S. Quantitative analysis of seven-pinhole tomographic thallium-201 scintigrams: improved sensitivity and estimation of the extent of coronary involvement by evaluation of radiotracer uptake and clearance. J Am Coll Cardiol. 1984 May; 3(5):1178-86. PMID: 6608548.
      View in: PubMed
    354. Massie BM, Wisneski JA, Inouye IK, Hollenberg M, Gertz EW, Henderson S. Detection and quantification of previous myocardial infarction by exercise-redistribution tomographic thallium-201 scintigraphy. Am J Cardiol. 1984 May 01; 53(9):1244-9. PMID: 6608868.
      View in: PubMed
    355. Massie BM, Kramer BL, Topic N. Long-term captopril therapy for chronic congestive heart failure. Am J Cardiol. 1984 May 01; 53(9):1316-20. PMID: 6231850.
      View in: PubMed
    356. Brundage BH, Massie BM, Botvinick EH. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol. 1984 Apr; 3(4):902-8. PMID: 6608546.
      View in: PubMed
    357. Inouye I, Massie B, Benowitz N, Simpson P, Loge D, Topic N. Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin. Am J Cardiol. 1984 Jan 27; 53(3):24A-28A. PMID: 6320622.
      View in: PubMed
    358. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, Tubau J. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol. 1984 Jan 01; 53(1):120-6. PMID: 6691248.
      View in: PubMed
    359. Massie BM, Hollenberg M, Wisneski JA, Go M, Gertz EW, Henderson S. Scintigraphic quantification of myocardial ischemia: a new approach. Circulation. 1983 Oct; 68(4):747-55. PMID: 6604588.
      View in: PubMed
    360. Massie BM. Myocardial hypertrophy and cardiac failure: a complex interrelationship. Am J Med. 1983 Sep 26; 75(3A):67-74. PMID: 6226198.
      View in: PubMed
    361. Massie BM, Packer M, Hanlon JT, Combs DT. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure. J Am Coll Cardiol. 1983 Aug; 2(2):338-44. PMID: 6345633.
      View in: PubMed
    362. Massie BM, Kramer BL, Topic N. Converting-enzyme inhibitor therapy for chronic heart failure. Herz. 1983 Apr; 8(2):71-80. PMID: 6343210.
      View in: PubMed
    363. Kramer BL, Massie BM, Topic N. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation. 1983 Apr; 67(4):807-16. PMID: 6337741.
      View in: PubMed
    364. Topic N, Kramer B, Massie B. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. Am Heart J. 1982 Nov; 104(5 Pt 2):1172-9. PMID: 6291362.
      View in: PubMed
    365. Awan NA, Massie BM. Therapy of severe chronic congestive heart failure. Am Heart J. 1982 Nov; 104(5 Pt 2):1125-6. PMID: 6753549.
      View in: PubMed
    366. Massie BM, Kramer BL, Topic N. Acute and long-term effects of captopril on left and right ventricular volumes and function in chronic heart failure. Am Heart J. 1982 Nov; 104(5 Pt 2):1197-203. PMID: 6291366.
      View in: PubMed
    367. Kramer B, Massie B, Topic N. Hemodynamic differences between supine and upright exercise in patients with congestive heart failure. Circulation. 1982 Oct; 66(4):820-5. PMID: 7116598.
      View in: PubMed
    368. Massie BM, Stern R, Hanlon JT, Haughom F. Beneficial hemodynamic effects of intravenous diazoxide in refractory congestive heart failure. Am Heart J. 1982 Sep; 104(3):581-6. PMID: 7113899.
      View in: PubMed
    369. Packer M, Greenberg B, Massie B, Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med. 1982 Jun 03; 306(22):1326-31. PMID: 7070457.
      View in: PubMed
    370. Massie B, Kramer BL, Topic N, Henderson SG. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise. Circulation. 1982 Jun; 65(7):1374-81. PMID: 6280890.
      View in: PubMed
    371. Massie BM, Wisneski J, Kramer B, Hollenberg M, Gertz E, Stern D. Comparison of myocardial thallium-201 clearance after maximal and submaximal exercise: implications for diagnosis of coronary disease: concise communication. J Nucl Med. 1982 May; 23(5):381-5. PMID: 7077392.
      View in: PubMed
    372. Massie BM, Kramer BL, Gertz EW, Henderson SG. Radionuclide measurement of left ventricular volume: comparison of geometric and counts-based methods. Circulation. 1982 Apr; 65(4):725-30. PMID: 7060252.
      View in: PubMed
    373. Kramer B, Topic N, Massie B. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. Br J Clin Pharmacol. 1982; 14 Suppl 2:143S-151S. PMID: 6753895; PMCID: PMC1427515.
    374. Massie BM, Chan S. Antihypertensive therapy with prazosin in patients with left ventricular dysfunction. Improvement in cardiac performance and exercise tolerance. Chest. 1981 Dec; 80(6):692-7. PMID: 7307590.
      View in: PubMed
    375. Massie BM, Kramer B, Haughom F. Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance. Circulation. 1981 Dec; 64(6):1218-26. PMID: 6794935.
      View in: PubMed
    376. Massie BM, Bharati S, Scheinman MM, Lev M, Desai J, Rubeson E, Schmidt W. Primary oxalosis with pan-conduction cardiac disease: electrophysiologic and anatomic correlation. Circulation. 1981 Oct; 64(4):845-52. PMID: 6456088.
      View in: PubMed
    377. Massie B, Botvinick E, Arnold S, Shames D, Brundage B, Hanlon JT, Sheldon K. Contrast enhancement of thallium-201 myocardial scintigrams: improved sensitivity with diminished specificity in coronary disease detection. Am Heart J. 1981 Jul; 102(1):37-44. PMID: 7246411.
      View in: PubMed
    378. Massie BM, Kramer B, Shen E, Haughom F. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. Br Heart J. 1981 Apr; 45(4):376-84. PMID: 7225252; PMCID: PMC482537.
    379. Desai JM, Scheinman MM, Strauss HC, Massie B, O'Young J. Electrophysiologic effects on combined autonomic blockade in patients with sinus node disease. Circulation. 1981 Apr; 63(4):953-60. PMID: 7471352.
      View in: PubMed
    380. Massie B, Kramer B, Haughom F. Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure. Circulation. 1981 Mar; 63(3):658-64. PMID: 6780233.
      View in: PubMed
    381. Massie B, Ports T, Chatterjee K, Parmley W, Ostland J, O'Young J, Haughom F. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation. 1981 Feb; 63(2):269-78. PMID: 6778625.
      View in: PubMed
    382. Chatterjee K, Rouleau JL, Massie BM. Hydralazine in chronic CHF. Acta Med Scand Suppl. 1981; 652:99-113. PMID: 6949469.
      View in: PubMed
    383. Hanlon JT, Massie B, Riches W, Wilson J, Ellis RJ, Gertz EW. Rapidly progressive coronary artery bypass graft atherosclerosis. Report of a case documented by serial coronary arteriograms and pathologic examination. Chest. 1981 Jan; 79(1):96-9. PMID: 6969650.
      View in: PubMed
    384. Greenberg BH, Massie BM. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis. Circulation. 1980 Jun; 61(6):1212-6. PMID: 7371134.
      View in: PubMed
    385. Chatterjee K, Ports TA, Brundage BH, Massie B, Holly AN, Parmley WW. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. Ann Intern Med. 1980 May; 92(5):600-4. PMID: 7386999.
      View in: PubMed
    386. Botvinick EH, Dunn RF, Hattner RS, Massie BM. A consideration of factors affecting the diagnostic accuracy of thallium-201 myocarial perfusion scintigraphy in detecting coronary artery disease. Semin Nucl Med. 1980 Apr; 10(2):157-67. PMID: 6994235.
      View in: PubMed
    387. Massie B, Botvinick EH, Brundage BH. Correlation of thallium-201 scintigrams with coronary anatomy: factors affecting region by region sensitivity. Am J Cardiol. 1979 Oct; 44(4):616-22. PMID: 484492.
      View in: PubMed
    388. Dash H, Massie B, Botvinick EH, Brundage BH. The noninvasive identification of left main and three-vessel coronary artery disease by myocardial stress perfusion scintigraphy and treadmill exercise electrocardiography. Circulation. 1979 Aug; 60(2):276-84. PMID: 445745.
      View in: PubMed
    389. Bharati S, Bauernfiend R, Scheinman M, Massie B, Cheitlin M, Denes P, Wu D, Lev M, Rosen KM. Congenital abnormalities of the conduction system in two patients with tachyarrhythmias. Circulation. 1979 Mar; 59(3):593-606. PMID: 761340.
      View in: PubMed
    390. Massie B, Botvinick EH, Werner JA, Chatterjee K, Parmley WW. Myocardial scintigraphy with technetium-99m stannous pyrophosphate: an insensitive test for nontransmural myocardial infarction. Am J Cardiol. 1979 Feb; 43(2):186-92. PMID: 760473.
      View in: PubMed
    391. Massie B, Chatterjee K. Vasodilator therapy of pump failure complicating acute myocardial infarction. Med Clin North Am. 1979 Jan; 63(1):25-51. PMID: 107378.
      View in: PubMed
    392. Massie B. Assessing the severity of aortic stenosis. Ann Intern Med. 1979 Jan; 90(1):123-4. PMID: 420445.
      View in: PubMed
    393. Massie B, Botvinick EH, Brundage BH, Greenberg B, Shames D, Gelberg H. Relationship of regional myocardial perfusion to segmental wall motion: a physiologic basis for understanding the presence and reversibility of asynergy. Circulation. 1978 Dec; 58(6):1154-63. PMID: 709771.
      View in: PubMed
    394. Massie B, Kleid JJ, Schiller N. Echocardiography in ischemic heart disease: present status and future prospectives. Am Heart J. 1978 Oct; 96(4):543-9. PMID: 358817.
      View in: PubMed
    395. Schor RA, Massie B, Botvinick EH, Shames DM. Gallium-67 uptake in silent myocardial infarction: a case report. Radiology. 1978 Oct; 129(1):117-8. PMID: 693859.
      View in: PubMed
    396. Greenberg BH, Massie BM, Brundage BH, Botvinick EH, Parmley WW, Chatterjee K. Beneficial effects of hydralazine in severe mitral regurgitation. Circulation. 1978 Aug; 58(2):273-9. PMID: 668075.
      View in: PubMed
    397. Massie B, Scheinman MM, Peters R, Desai J, Hirschfeld D, O'Young J. Clinical and electrophysiologic findings in patients with paroxysmal slowing of the sinus rate and apparent Mobitz type II atrioventricular block. Circulation. 1978 Aug; 58(2):305-14. PMID: 668079.
      View in: PubMed
    398. Chatterjee K, Massie B, Rubin S, Gelberg H, Brundage BH, Ports TA. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise. Am J Med. 1978 Jul; 65(1):134-45. PMID: 99031.
      View in: PubMed
    399. Scheinman MM, Strauss HC, Evans GT, Ryan C, Massie B, Wallace A. Adverse effects of sympatholytic agents in patients with hypertension and sinus node dysfunction. Am J Med. 1978 Jun; 64(6):1013-20. PMID: 655187.
      View in: PubMed
    400. Sharpe DN, Botvinick EH, Shames DM, Schiller NB, Massie B, Chatterjee K, Parmley WW. The noninvasive diagnosis of right ventricular infarction. Circulation. 1978 Mar; 57(3):483-90. PMID: 624158.
      View in: PubMed
    401. Massie B, Botvinick EH, Shames D, Taradash M, Werner J, Schiller N. Myocardial perfusion scintigraphy in patients with mitral valve prolapse: Its advantage over stress electrocardiography in diagnosing associated coronary artery disease and its implications for the etiology of chest pain. Circulation. 1978 Jan; 57(1):19-26. PMID: 618388.
      View in: PubMed
    402. Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol. 1977 Nov; 40(5):794-801. PMID: 411364.
      View in: PubMed
    403. Massie B, Schiller NB, Ratshin RA, Parmley WW. Mitral-septal separation: new echocardiographic index of left ventricular function. Am J Cardiol. 1977 Jun; 39(7):1008-16. PMID: 868766.
      View in: PubMed
    404. Tyberg JV, Massie B, Botvinick EH, Parmley W. The hemodynamics of coronary arterial stenosis. Cardiovasc Clin. 1977; 8(2):71-84. PMID: 332373.
      View in: PubMed
    405. Chatterjee K, Parmley WW, Massie B, Greenberg B, Werner J, Klausner S, Norman A. Oral hydralazine therapy for chronic refractory heart failure. Circulation. 1976 Dec; 54(6):879-83. PMID: 825327.
      View in: PubMed
    Barry's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP